Back to search
FDAFDA · Food and drugs·Recall number D-0295-2026

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Published January 28, 2026 · Recall initiated: December 30, 2025

Summary

FDA records drug Class II recall D-0295-2026, published January 28, 2026 and initiated December 30, 2025. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Ongoing; Reported quantity: 22,896 bottles; Lot: Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
US Nationwide.
Lot
Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07 recalled?

Yes. FDA published recall D-0295-2026 on January 28, 2026. Reported hazard: Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter